Atlas Trials

Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis Participants

Clinical trial NCT04410198 · COMPLETED

Trial details

NCT number
NCT04410198
Sponsor
Kyntra Bio
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Anemia Associated With End Stage Renal Disease (ESRD)
Start date
2020-05-26
Primary completion
2021-06-30
Enrollment
203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.